https://sciex.com/content/SCIEX/na/us/en


Maximize the use of your software. Buy only what you need

Dec 11, 2017 | Blogs, Software, Technology | 0 comments

The latest releases of Analyst Software 1.7 and SCIEX OS Software 1.4 introduce a new licensing model called concurrent licensing. If you want flexibility and cost savings when purchasing and using your processing software, concurrent licensing is for you.

How does it work? Concurrent licenses float through the network and are passed from user to user, machine to machine. In other words, access to the software can be granted based on the number of licenses expected to be used at the same time.

So what, you ask? Good question.

The concurrent licensing model can be significantly less costly for your organization than the single device model. This means your tier 2 and tier 3 lab analyst with lower software utilization rates can now share access easily especially when access is not needed at the same time. Get a Better Understanding of Concurrent Software Licenses >

By choosing the concurrent licensing model, your organization can be more:

  • Thrifty:  Avoid overpaying for software licenses and effectively manage your software spend. Track your team’s true software consumption and easily cancel unused licenses; while share underutilized licenses within the team
  • Strategic: Simplifies administration as you can manage licenses for multiple users from one central platform and consolidate license renewal dates across your organization
  • Productive: Allows on-demand license access for local and remote teams within same time zone so users can access the software from any device within the network
  • Diligent: Ensure license compliance and eliminate the potential of costly and unexpected audit penalties

Enjoy the benefits of SCIEX software solutions and take full advantage of the flexible licensing model for your processing software.

For more questions on licensing, get in touch with our software sales specialists >

Supporting new CRISPR gene editing systems

Prime editing (PE) is a next-generation gene editing technology that utilizes a Cas9 protein fused to a prime editing guide ribonucleic acid (pegRNA) to achieve high CRISPR/Cas9 editing efficiency and precision. However, the length requirement of pegRNAs at 120–250 nucleotides (nt) and their high level of secondary structure formation present analytical challenges for the purity analysis of chemically synthesized pegRNAs during development and quality control (QC).

A new approach for comprehensive AAV evaluation including full and empty analysis

Certain next-gen vaccines and gene therapy applications rely on the usage of adeno-associated viruses (AAV) as a delivery vehicle. To ensure the safety and efficacy of viral vector drugs, multiple critical quality attributes (CQAs) need to be well characterized.

The rising tide of food allergies: Common questions and crucial insights

Allergy policies for nut-free commercial flights and nut-free childcare settings are not a rare occurrence nowadays—the reason is a rise in food allergies. Nuts are the most potent allergenic foods in terms of the amount that is required to elicit an allergic reaction and the severity of those reactions.

Posted by

0 Comments

Submit a Comment

Wordpress Social Share Plugin powered by Ultimatelysocial